Kedrion SpA, an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products, has named Val Romberg as its new CEO, it was reported on Friday.
Romberg has served for forty years at companies including West Pharmaceutical Services, Aventis Behring, ZLB Behring and CSL Behring. Most recently, he was the executive vice president of operations for CSL Behring.
Romberg said, said, 'I am very happy to join Kedrion, which produces and distributes essential therapeutic treatments for patients around the world. I am particularly pleased that this is coming as the company makes progress with the development of new therapeutic treatments for COVID-19 in collaboration with its research partner, the Irving Medical Center at the University of Colombia.'
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer